Cresemba and Flonase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Flonase (fluticasone propionate). Common drug interactions include death among females and fungal infection among males.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Flonase. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Flonase?

Flonase has active ingredients of fluticasone propionate. It is often used in allergies. eHealthMe is studying from 75,441 Flonase users. Check the latest studies of Flonase.

On Aug, 05, 2026

37 people who take Cresemba and Flonase together, and have interactions are studied.

What are the common drug interactions of Cresemba and Flonase, by gender? *:

female:

Death
Diverticulum intestinal (a pouch that is attached to the first part of the small intestine)
Dyspnoea (difficult or laboured respiration)
Eosinophil count decreased
Gait disturbance
Gastric mucosal lesion (lesion of stomach mucous membrane)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Haemochromatosis (body to absorb more iron than usual from food)
Headache (pain in head)
Hyperglycaemia (high blood sugar)

male:

Fungal infection
Drug ineffective
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Acute respiratory failure
Anxiety
Back pain
Blood glucose increased
Blood pressure increased
Confusional state
Constipation

What are the common drug interactions of Cresemba and Flonase, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Decreased appetite
Dehydration (dryness resulting from the removal of water)
Lung transplant rejection (failure of lung transplant)
Tenderness (pain or discomfort when an affected area is touched)

30-39:

Pneumonia

40-49:

Acute respiratory failure
Febrile neutropenia (fever with reduced white blood cells)
Pancreatitis acute (sudden inflammation of pancreas)
Pneumonia
Thrombocytopenia (decrease of platelets in blood)

50-59:

Cystic fibrosis (disease of the secretary glands)
Pneumonia
Intestinal obstruction
Oral discomfort (pain or irritation in mouth)
Pain in extremity
Pneumonia bacterial (pneumonia associated with bacterial infection)

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Nausea (feeling of having an urge to vomit)
Anxiety
Back pain
Blood glucose increased
Blood pressure increased
Confusional state
Constipation
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Deafness

What are the existing conditions these people have? *

Cystic Fibrosis (disease of the secretary glands): 11 people, 29.73%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 18.92%
Pain: 6 people, 16.22%
Nausea (feeling of having an urge to vomit): 5 people, 13.51%
Insomnia (sleeplessness): 5 people, 13.51%
Nausea And Vomiting: 4 people, 10.81%
Hypersensitivity: 4 people, 10.81%
Renal Cell Carcinoma (a kidney cancer): 3 people, 8.11%
Pain In Extremity: 3 people, 8.11%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 8.11%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Flonase?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously